Literature DB >> 22123056

The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge.

Randall J Brezski1, Allison Oberholtzer, Brandy Strake, Robert E Jordan.   

Abstract

The mammalian antibody repertoire comprises immunoglobulin (Ig) molecules of multiple isotypes and subclasses with varying functional properties. Among the four subclasses of the human IgG isotype, we found that IgG2 exhibits a particular resistance to human and bacterial proteases that readily cleave the IgG1 hinge region in vitro. Autoantibodies (IgGs) that recognize points of proteolytic cleavage in the IgG1 hinge are widespread in the healthy human population, suggesting that IgG1 fragmentation and the generation of cryptic antigens for host immune surveillance commonly occur in vivo. We previously reported that autoantibodies to cleaved IgG1s can restore Fc-mediated effector functions that are lost following proteolytic cleavage of the hinge. In contrast, it was not possible to demonstrate an analogous cohort of autoantibodies to IgG2 hinge epitope analogs, and there appeared to be no functional component in human serum with the ability to reconstitute Fc effector functions to a cell-bound IgG2 fragment. Thus, the results indicate that among the IgG subclasses, human IgG2 is uniquely resistant to a number of known pathological proteases and that autoimmune recognition to potential cleavage points in the IgG2 hinge appears to be absent in human circulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123056      PMCID: PMC3242842          DOI: 10.4161/mabs.3.6.18119

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  38 in total

1.  Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin.

Authors:  Andrew J H Gearing; Susan J Thorpe; Karen Miller; Matthew Mangan; Paul G Varley; Tim Dudgeon; George Ward; Christina Turner; Robin Thorpe
Journal:  Immunol Lett       Date:  2002-04-01       Impact factor: 3.685

2.  High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.

Authors:  R L Shields; A K Namenuk; K Hong; Y G Meng; J Rae; J Briggs; D Xie; J Lai; A Stadlen; B Li; J A Fox; L G Presta
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

3.  Human IgG2 can form covalent dimers.

Authors:  Esther M Yoo; Letitia A Wims; Lisa A Chan; Sherie L Morrison
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

4.  Relationship between the papain sensitivity of human gammaG immunoglobulins and their heavy chain subclass.

Authors:  R Jefferis; P D Weston; D R Stanworth; J R Clamp
Journal:  Nature       Date:  1968-08-10       Impact factor: 49.962

5.  Pepsin digestion of human G-myeloma proteins of different subclasses. I. The characteristic features of pepsin cleavage as a function of time.

Authors:  M W Turner; H H Bennich; J B Natvig
Journal:  Clin Exp Immunol       Date:  1970-11       Impact factor: 4.330

6.  The covalent structure of an entire gammaG immunoglobulin molecule.

Authors:  G M Edelman; B A Cunningham; W E Gall; P D Gottlieb; U Rutishauser; M J Waxdal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-05       Impact factor: 11.205

7.  IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G.

Authors:  Ulrich von Pawel-Rammingen; Björn P Johansson; Lars Björck
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

8.  Kinetics of the different susceptibilities of the four human immunoglobulin G subclasses to proteolysis by human lysosomal elastase.

Authors:  A Baici; M Knöpfel; K Fehr; F Skvaril; A Böni
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

9.  Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis.

Authors:  J E Persselin; R H Stevens
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  R B Fick; R S Baltimore; S U Squier; H Y Reynolds
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

View more
  13 in total

1.  A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.

Authors:  Randall J Brezski; Michelle Kinder; Katharine D Grugan; Keri L Soring; Jill Carton; Allison R Greenplate; Theodore Petley; Dorie Capaldi; Kerry Brosnan; Eva Emmell; Sharon Watson; Robert E Jordan
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

2.  Evading pre-existing anti-hinge antibody binding by hinge engineering.

Authors:  Hok Seon Kim; Ingrid Kim; Linda Zheng; Jean-Michel Vernes; Y Gloria Meng; Christoph Spiess
Journal:  MAbs       Date:  2016-08-09       Impact factor: 5.857

3.  Engineering a human IgG2 antibody stable at low pH.

Authors:  Seiji Saito; Hiroshi Namisaki; Keiko Hiraishi; Nobuaki Takahashi; Shigeru Iida
Journal:  Protein Sci       Date:  2020-03-18       Impact factor: 6.725

4.  The solution structure of the human IgG2 subclass is distinct from those for human IgG1 and IgG4 providing an explanation for their discrete functions.

Authors:  Gar Kay Hui; Antoni D Gardener; Halima Begum; Charles Eldrid; Konstantinos Thalassinos; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2019-05-14       Impact factor: 5.157

5.  Engineered protease-resistant antibodies with selectable cell-killing functions.

Authors:  Michelle Kinder; Allison R Greenplate; Katharine D Grugan; Keri L Soring; Katharine A Heeringa; Stephen G McCarthy; Gregory Bannish; Meredith Perpetua; Frank Lynch; Robert E Jordan; William R Strohl; Randall J Brezski
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

6.  Cleavage of IgG1 in gingival crevicular fluid is associated with the presence of Porphyromonas gingivalis.

Authors:  A Guentsch; C Hirsch; W Pfister; B Vincents; M Abrahamson; A Sroka; J Potempa; S Eick
Journal:  J Periodontal Res       Date:  2012-11-01       Impact factor: 4.419

7.  Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cells.

Authors:  Tao Huang; Mary Mathieu; Sophia Lee; Xinhua Wang; Yee Seir Kee; Jack J Bevers; Claudio Ciferri; Alberto Estavez; Manda Wong; Nancy Y Chiang; Gerald Nakamura; Randall J Brezski
Journal:  J Biol Chem       Date:  2017-11-30       Impact factor: 5.157

8.  An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.

Authors:  Michelle Kinder; Allison R Greenplate; William R Strohl; Robert E Jordan; Randall J Brezski
Journal:  MAbs       Date:  2015       Impact factor: 5.857

9.  Pharmacokinetics and pharmacodynamics of recombinant human EPO-Fc fusion protein in vivo.

Authors:  Xunlong Shi; Jianjun Yang; Haiyan Zhu; Li Ye; Meiqing Feng; Jiyang Li; Hai Huang; Qun Tao; Dan Ye; Lee-Hwei K Sun; Bill N C Sun; Cecily R Y Sun; Guizhen Han; Yuanyuan Liu; Minghui Yao; Pei Zhou; Dianwen Ju
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

10.  Comparability of a three-dimensional structure in biopharmaceuticals using spectroscopic methods.

Authors:  Víctor Pérez Medina Martínez; Mario E Abad-Javier; Alexis J Romero-Díaz; Francisco Villaseñor-Ortega; Néstor O Pérez; Luis F Flores-Ortiz; Emilio Medina-Rivero
Journal:  J Anal Methods Chem       Date:  2014-05-22       Impact factor: 2.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.